Legal Representation
Attorney
Lori J. Shyavitz
USPTO Deadlines
Next Deadline
41 days remaining
NOA E-Mailed - SOU Required
Due Date
August 25, 2025
Extension Available
Until February 25, 2026
Application History
22 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Feb 25, 2025 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Dec 31, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Dec 31, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Dec 25, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Oct 22, 2024 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Oct 22, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Oct 22, 2024 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Oct 22, 2024 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Oct 22, 2024 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Oct 7, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Sep 24, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Sep 23, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Sep 23, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jun 24, 2024 | XELG | O | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | Loading... |
| Jun 24, 2024 | XELR | I | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | Loading... |
| Mar 22, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Mar 22, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Mar 22, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Mar 15, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jan 24, 2024 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | Loading... |
| Aug 3, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jul 6, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for the treatment of cancer, infectious disease, metabolic disease, and central nervous system disease; chemico-pharmaceutical preparations for the treatment of cancer, infectious disease, metabolic disease, and central nervous system disease; drugs for medical purposes, namely, anticancer preparations; biological preparations for the treatment of cancer, infectious disease, metabolic disease, and central nervous system disease; chemical preparations for pharmaceutical or medical purposes, namely, for the treatment of cancer, infectious disease, metabolic disease, and central nervous system disease; medicinal preparations for human purposes for the treatment of cancer, infectious disease, metabolic disease, and central nervous system disease; pharmaceutical preparations, substances and compositions for the prevention of cancer, infectious disease, metabolic disease, and central nervous system disease and conditions
Class 040
Custom manufacturing of pharmaceuticals, biological preparations and drug conjugates; custom assembly of pharmaceuticals, biological preparations and drug conjugates; custom manufacturing of pharmaceuticals; custom production of pharmaceuticals; custom production of biological preparations; custom manufacturing of chemical reagents; custom manufacturing of pharmaceutical preparations; custom manufacturing of biomedical preparations; custom manufacture of drug conjugates
Class 042
Scientific and engineering research services relating to the manufacture of biotechnology and pharmaceutical products; development of products for others; pharmaceutical drug development services; research and development of new products; biochemical research and development; custom design and development of chemical reagents, pharmaceutical formulations, and biologics; research and development in the pharmaceutical, biomedicine and biotechnology fields; research and development of nucleic acid medicines; research and development of mRNA drug substance and drug products; biomedical research services; development of pharmaceutical preparations and medicines
Additional Information
Pseudo Mark
KUDO BIO TECHNOLOGY
Classification
International Classes
005
040
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"BIOTECHNOLOGY"